RARE - Ultragenyx Pharmaceutical Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - RARE (1515673)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
39 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2026-03-02
RAREPinion John RichardSee RemarksS - Sale$22.80-10,029110,026-8%-$228,661
2026-03-02
RAREHarris ErikEVP, Chief Commercial OfficerS - Sale$22.80-10,53989,515-11%-$240,289
2026-03-02
RAREKakkis Emil DPres, CEOS - Sale$22.80-54,4042,817,979-2%-$1,240,411
2026-03-02
RAREParschauer Karah HerdmanEVP, GCS - Sale$22.80-8,13576,346-10%-$185,478
2026-03-02
RAREHuizenga Theodore AlanSVP, Chief Accounting OfficerS - Sale$22.80-1,63248,670-3%-$37,210
M
2026-03-02
RAREHorn HowardCFOS - Sale$22.65-10,04485,034-11%-$227,538
2026-03-02
RARECrombez EricEVP, Chief Medical OfficerS - Sale$22.80-7,02976,301-8%-$160,261
2026-02-02
RAREHorn HowardCFOS - Sale$23.56-3,06188,935-3%-$72,117
2026-01-02
RAREHorn HowardCFOS - Sale$22.84-3,15091,996-3%-$71,946
2025-12-29
RAREHuizenga Theodore AlanSVP, Chief Accounting OfficerS - Sale$34.38-8550,4500%-$2,922
2025-12-10
RAREHorn HowardCFOS - Sale$36.38-3,08195,146-3%-$112,087
2025-10-13
RAREHorn HowardCFOS - Sale$31.51-7,94298,227-7%-$250,252
2025-09-18
RAREHuizenga Theodore AlanSVP, Chief Accounting OfficerS - Sale$29.17-6450,2420%-$1,867
2025-09-12
RAREParschauer Karah HerdmanEVP, GCS - Sale$31.17-2,45073,271-3%-$76,367
2025-09-05
RAREHuizenga Theodore AlanSVP, Chief Accounting OfficerS - Sale$31.39-8450,3060%-$2,637
2025-06-20
RARESanders Corazon (Corsee) D.DirS - Sale$37.39-2,40515,344-14%-$89,923
M
2025-04-21
RARECrombez EricEVP, Chief Medical OfficerS - Sale$37.93-76271,530-1%-$28,901
2025-03-06
RAREHorn HowardCFOS - Sale$40.40-1,785106,169-2%-$72,114
2025-03-03
RAREKassberg Thomas RichardCBO, EVPS - Sale$42.10-6,028264,730-2%-$253,779
2025-03-03
RAREParschauer Karah HerdmanEVP, GCS - Sale$42.10-12,84675,287-15%-$540,817
D
2025-03-03
RARECrombez EricEVP, Chief Medical OfficerS - Sale+OE$42.10-8,94571,922-11%-$376,585
D
2025-03-03
RAREPinion John RichardSee RemarksS - Sale+OE$42.10-14,439108,428-12%-$607,882
DM
2025-03-03
RAREKakkis Emil DPres, CEOS - Sale+OE$42.20-98,4342,800,716-3%-$4,153,571
D
2025-03-03
RAREHarris ErikEVP, Chief Commercial OfficerS - Sale+OE$42.10-15,10387,855-15%-$635,836
D
2025-03-03
RAREHuizenga Theodore AlanSVP, Chief Accounting OfficerS - Sale+OE$42.10-96750,124-2%-$40,711
D
2025-02-27
RAREParschauer Karah HerdmanEVP, GCS - Sale+OE$42.88-2,99069,690-4%-$128,224
2024-12-30
RAREKakkis Emil DPres, CEOS - Sale$42.23-11,7272,748,5900%-$495,231
2024-12-10
RAREKakkis Emil DPres, CEOS - Sale$50.00-8,2732,760,3170%-$413,650
2024-10-10
RAREHorn HowardCFOS - Sale$52.76-7,46592,301-7%-$393,853
2024-09-03
RAREKakkis Emil DPres, CEOS - Sale$55.85-20,0002,788,582-1%-$1,117,000
2024-09-03
RAREHuizenga Theodore AlanSVP, Chief Accounting OfficerS - Sale$56.19-9141,5510%-$5,113
2024-08-06
RAREKakkis Emil DPres, CEOS - Sale$50.17-20,0002,808,582-1%-$1,003,400
2024-07-02
RARESanders Corazon (Corsee) D.DirS - Sale$40.98-58412,009-5%-$23,932
2024-06-12
RAREParschauer Karah HerdmanEVP, GCS - Sale$45.00-9,80657,981-14%-$441,270
2024-06-10
RARESanders Corazon (Corsee) D.DirS - Sale$41.10-1,7377,248-19%-$71,391
2024-05-02
RARECrombez EricEVP, Chief Medical OfficerS - Sale$43.66-35448,431-1%-$15,456
2024-04-18
RARECrombez EricEVP, Chief Medical OfficerS - Sale$44.10-14248,7850%-$6,262
2024-03-11
RAREKassberg Thomas RichardCBO, EVPS - Sale$49.93-11,509252,823-4%-$574,644
2024-03-07
RAREFust Matthew KDirS - Sale$50.88-12,19514,860-45%-$620,443

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top